September 22, 2014 / 2:18 PM / in 4 years

BUZZ-Tekmira Pharmaceuticals Corp: FDA authorizes emergency use of Ebola treatment

** Canadian biopharmaceutical’s shares up 6.4 pct at C$24.07

** U.S. Food and Drug Administration authorizes emergency use of Tekmira’s ebola treatment under expanded access protocol to confirmed or suspected patients

** This comes two weeks after the World Health Organization urged pharmaceutical companies and regulatory agencies to work together to accelerate development of safe drugs and vaccines against Ebola

** Expanded access lets drug developers offer experimental therapies to patients with serious diseases who cannot participate in controlled clinical trials

** FDA last month lifted partial hold on Tekmira’s Ebola treatment, codenamed TKM-Ebola, to enable potential use in infected humans

** Up to Friday’s close, stock had risen 45 pct after the company’s FDA lifted partial hold on the treatment in August (Reuters Messaging:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below